The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids-Reference-Cited by-同舟云学术

The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids

Published:1992-04 Issue:2 Volume:27 Page:222-229
ISSN:0435-1339
Container-title:Gastroenterologia Japonica
language:en
Short-container-title:Gastroenterol Jpn

Author:

Higuchi Tomoyuki,Hishida Naoki,Isomura Toyoshi,Takeshima Hirotomo,Hayashi Hisao

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF02777726.pdf

Reference24 articles.

1. Jain S, Scheuer PJ, Samourian S, et al: A controlled trial of D-penicillamine in primary biliary cirrhosis. Lancet 1977;l:831–834.

2. Crowe J, Christensen E, Smith M, et al: Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial. Gastroenterology 1980;78:1005–1010.

3. Kaplan MM, Ailing DW, Zimmerman HJ, et al: A prospective trial of colchicine for primary biliary cirrhosis. Gastroenterology 1986;92:255–257.

4. Fischer MM, Paradine ME: Influence of ursodeoxycholic acid (UDCA) on biochemical parameters in cholestatic liver disease (abstr). Gastroenterology 1986; 90:1725.

5. Poupon R, Chretien Y, Poupon RE, et al: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987;2:834–836.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined phlebotomy and ursodeoxycholic acid treatment in the patients with chronic hepatitis C;Hepatology Research;2000-07

2. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis;European Journal of Gastroenterology & Hepatology;1999-10

3. BILE ACID ABNORMALITIES IN CHOLESTATIC LIVER DISEASES;Gastroenterology Clinics of North America;1999-03